These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9931922)

  • 21. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia.
    Ajisaka H; Yonemura Y; Bando E; Fushida S; Nishimura G; Miwa K
    Hepatogastroenterology; 2002; 49(46):1027-9. PubMed ID: 12143193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent micropapillary serous ovarian carcinoma.
    Bristow RE; Gossett DR; Shook DR; Zahurak ML; Tomacruz RS; Armstrong DK; Montz FJ
    Cancer; 2002 Aug; 95(4):791-800. PubMed ID: 12209723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
    Psyrri A; Bamias A; Yu Z; Weinberger PM; Kassar M; Markakis S; Kowalski D; Efstathiou E; Camp RL; Rimm DL; Dimopoulos MA
    Clin Cancer Res; 2005 Dec; 11(23):8384-90. PubMed ID: 16322299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of ovarian serous papillary adenocarcinoma combined with malignant endosalpingiosis].
    Mizutani H; Katabuchi H; Nakamura M; Matsuura K; Ito M; Okamura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1139-42. PubMed ID: 8245594
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovarian surface serous papillary carcinomas: a clinicopathologic study.
    Liapis A; Condi-Paphiti A; Pyrgiotis E; Zourlas PA
    Eur J Gynaecol Oncol; 1996; 17(1):79-82. PubMed ID: 8750521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
    Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M
    Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
    Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
    Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
    Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
    Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
    Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H
    Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stage I ovarian carcinoma: different clinical pathologic patterns.
    Deligdisch L; Pénault-Llorca F; Schlosshauer P; Altchek A; Peiretti M; Nezhat F
    Fertil Steril; 2007 Oct; 88(4):906-10. PubMed ID: 17920404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.
    Hasenburg A; Tong XW; Rojas-Martinez A; Nyberg-Hoffman C; Kieback CC; Kaplan A; Kaufman RH; Ramzy I; Aguilar-Cordova E; Kieback DG
    Cancer Gene Ther; 2000 Jun; 7(6):839-44. PubMed ID: 10880013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF; Liu FY; Chen FJ; Feng YL
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up.
    Yoshida Y; Sasaki H; Kurokawa T; Kawahara K; Shukunami K; Katayama K; Yamaguchi A; Kotsuji F
    Oncol Rep; 2005 Jan; 13(1):121-5. PubMed ID: 15583812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos HP; Efstathiou E; Salamalekis E; Farmakis D; Skarlos D; Briasoulis E; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2005 May; 97(2):436-41. PubMed ID: 15863142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of prognostic factors of stage IV epithelial ovarian cancer].
    Gao J; Zheng A; Chen W; Peng Z; Cao Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):309-12. PubMed ID: 12600118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.